ASA. A. Svishcheva

A. A. Svishcheva

*This is an algorithmically generated author record based on publicly available information.

A. A. Svishcheva has a total of 54 co-authors. Here are the top co-authors by number of shared publications:

  • Oksana Mikhailovna Drapkina

    National Medical Research Center for Therapy and Preventive Medicine, Ministry of Health of Russia

    8 shared publications
  • Ruslan Nikolaevich Shepel

    National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation

    8 shared publications
  • Evgenia A. Lavrenova

    National Medical Research Center for Therapy and Preventive Medicine

    3 shared publications
  • L. Yu. Drozdova

    National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation

    3 shared publications
  • А. А. Свищева

    ФГБУ "Национальный медицинский исследовательский центр терапии и профилактической медицины" Минздрава России

    3 shared publications
  • Р. Н. Шепель

    ФГБУ "Национальный медицинский исследовательский центр терапии и профилактической медицины" Минздрава России. Москва

    3 shared publications

Latest Publications

  • Open Access

    Management of patients with osteoarthritis in an outpatient setting: guidelines (for primary healthcare professionals: primary care physicians, general practitioners)

    by O. M. Drapkina, A. M. Lila, E. A. Taskina, S. А. Berns, A. A. Svishcheva, S. A. Smakotina, I. A. Skripnikova, R. N. Shepel, О. М. Драпкина, А. М. Лила, et al.

    These guidelines outline the fundamental principles for the diagnosis and treatment of osteoarthritis and cover strategic recommendations regarding treatment regimens with disease- modifying and symptomatic anti-inflammatory medications.    The guidelines  were developed based on the guidelines of the American College of Rheumatology/Arthritis Foundation (ACR, 2019), the European Alliance of Associations for Rheumatology (EULAR, 2018), the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO, 2019), the American Academy of Orthopaedic Surgeons (AAOS, 2021), the Association of Rheumatologists of Russia (ARR, 2025), as well as publications from the Cochrane Library, PubMed (MEDLINE) databases, and current federal regulatory documents. These guidelines are intended for primary healthcare professionals — primary care physicians and general practitioners — as well as senior medical students.

  • Open Access

    Methodological approaches to forecasting the number of people with prediabetes at the regional level

    by I. M. Son, O. V. Medvedeva, L. I. Menshikova, S. A. Suslin, R. N. Shepel, A. A. Svishcheva, И. М. Сон, О. В. Медведева, Л. И. Меньшикова, С. А. Суслин, et al.

    Aim. To develop a methodology for forecasting the number of people with prediabetes at the regional level. Material and methods . The developed methodology is designed to calculate a short-term forecast of the number of individuals with prediabetes at the regional level. The source data are the results of preventive medical examinations (PME) and check-ups of specific adult population groups, which allow for the estimation of the number of newly diagnosed cases of prediabetes (based on fasting blood glucose levels). The methodology utilizes data from Form № 131/o, "Information on the conduct of preventive medical examinations and check-ups of specific adult population groups". The methodology accounts for incomplete population coverage and allows for the determination of the projected number of individuals with prediabetes among the entire adult population of a specific constituent entity of the Russian Federation. Mathematical, statistical and analytical research methods were employed. Results . The methodology involves calculating the following indicators: the PME and check-ups’ plan fulfillment rate, the actual prediabetes detection rate, the projected number of people with prediabetes for the next period assuming 100% fulfillment of the PME and check-ups’ plan, and the number and proportion of individuals with prediabetes among the entire attached adult population of the region. The methodology assumes an equal prevalence of prediabetes among those who have and have not undergone PME and check-ups’. The calculations are based on Form № 131/o data, which include only fasting glucose levels. Potential laboratory diagnostic errors are not taken into account. The forecast is relevant for one year and is not suitable for medium- or long-term calculations, which require follow-up analysis and complex models. Conclusion. A methodology for short-term forecasting of the number of individuals with prediabetes at the regional level has been developed. It is based on Form № 131/o data and accounts for incomplete coverage of the adult population by PME and check-ups. The methodology allows for the calculation of the projected number and proportion of individuals with prediabetes among the attached population. The resulting estimates can be used in planning clinical monitoring, preventive counseling, and organizational measures aimed at reducing the risk of type 2 diabetes.

  • Open Access

    Implementation of the "Regional Model for Managing Primary Health Care for Patients with Prediabetes". Guidelines

    by O. M. Drapkina, I. M. Son, L. I. Menshikova, O. V. Medvedeva, S. A. Suslin, R. N. Shepel, L. Yu. Drozdova, A. A. Svishcheva, О. М. Драпкина, И. М. Сон, et al.

    These guidelines were developed to provide organizational and methodological support for the implementation of the "Regional Model for Managing Primary Health Care for Patients with Prediabetes" program in Russian regions. The document aims to develop a unified approach to the early detection of prediabetes, patient referral, follow-up care, preventive counseling, training of healthcare workers, and evaluation of the effectiveness of interventions at the regional and institutional levels. The guidelines present the regulatory, organizational, medical, social, and educational components of the program, as well as propose a structure for the regional program's data sheet, a roadmap for its implementation, algorithms for administrative and managerial decisions, and approaches to registering patients with prediabetes. Particular attention is given to the system of performance criteria and indicators, including the detection of prediabetes during preventive measures, coverage of follow-up monitoring and preventive counseling, the proportion of trained healthcare workers, and the changes of type 2 diabetes cases among patients monitored for prediabetes. The proposed methodologies for calculating indicators allow for standardized monitoring of program implementation, comparative evaluation of health facilities, and the use of the obtained data for management decision-making. These guidelines are intended for specialists from executive authorities of the constituent entities of the Russian Federation in the field of healthcare, territorial compulsory health insurance funds, medical insurance organizations, heads of healthcare organizations, and specialists involved in providing primary healthcare to patients with prediabetes.

  • Open Access

    Assessment of the features of follow-up and implementation of treatment and preventive measures in patients with prediabetes in outpatient clinical practice in the Russian Federation (DIORAMA): rationale and study design

    by S. Yu. Martsevich, R. N. Shepel R. N., A. V. Zagrebelnyi, O. M. Drapkina, Yu. V. Lukina, A. A. Svishcheva, M. E. Zharova

    Aim . To assess the features of clinical follow-up (dispensary observation) and the implementation of preventive measures among patients with prediabetes in the context of outpatient clinical practice. Material and methods . The DIORAMA study (Features of dispensary observation and implementation of therapeutic and preventive measures in patients with “prediabetes” in outpatient clinical practice) is a multicenter, open-label, prospective, observational study planned to be conducted in 200 medical institutions across the Russian Federation, with up to 24,000 participants. The study will include adult patients with confirmed prediabetes (ICD-10 codes: R73.0 — impaired glucose tolerance and/or R73.9 — unspecified hyperglycemia, including impaired fasting glucose). The observation period will last for at least three years, with data collection at baseline, and at 1- and 2-year follow-ups. Data collected will include demographic, clinical, lifestyle anthropometric, laboratory, and instrumental parameters, as well as details on therapeutic interventions and their effectiveness over time. Additional tools will include the FINDRISC questionnaire and treatment adherence surveys. The primary endpoints are normalization of carbohydrate metabolism parameters and progression to type 2 diabetes mellitus (T2DM). Secondary endpoints include cardiovascular and all-cause mortality, incidence of myocardial infarction, stroke, acute coronary syndrome, and emergency myocardial revascularization. Results . This study will examine real-world data pertaining to patients with prediabetes, focusing on patterns of care delivery — specifically, visit frequency and the deployment of therapeutic and preventive measures — and their effectiveness. The analysis is designed to evaluate laboratory parameters and modifiable risk factors, track progression to T2DM, and assess the influence of lifestyle, adherence, and therapeutic regimens on clinical endpoints. Conclusion . The DIORAMA study is expected to provide, for the first time at the national level, a systematic overview of follow-up, therapeutic, and preventive measures for prediabetes in the Russian Federation. The findings will have high practical significance for developing organizational and methodological algorithms aimed at optimizing outpatient care, improving patient adherence to treatment, and reducing the risk of progression from prediabetes to T2DM.


  • Open Access

    Implementation of programs for early detection of type 2 diabetes mellitus and dispensary monitoring of patients with this disease in health care systems: international and national experience

    by O. M. Drapkina, A. A. Svishcheva, E. A. Lavrenova, R. N. Shepel

    Реализация программ раннего выявления сахарного диабета 2 типа и диспансерного наблюдения пациентов с данным заболеванием в системах здравоохранения: международный и отечественный опыт. Обзор литературы


  • Open Access

    Outpatient monitoring of patients with type 2 diabetes by a primary care physician. Guidelines

    by O. M. Drapkina, N. G. Mokrysheva, M. V. Shestakova, E. A. Lavrenova, P. V. Ipatov, I. N. Kononeko, T. A. Kunyaeva, M. A. Livzan, I. V. Druk, A. A. Svischeva, et al.

    The guidelines outline modern approaches to the diagnosis and treatment of type 2 diabetes, including clinical and paraclinical methods necessary for effective monitoring of patients’ condition. Key attention is paid to outpatient follow-up. Both drug and non-drug treatment methods are presented, aimed at preventing the progression of diabetes, reducing the risk of complications and improving the quality and duration of life of patients. Algorithmization and structuring of modern clinical guidelines and standards in terms of outpatient follow-up make the document relevant, practice-o riented and useful for health professionals. The inclusion of evidence data ensures the high efficiency of the proposed approaches and their application in routine health practice.The guidelines are intended for district internists, general practitioners (family doctors), district internists of the shop medical district, as well as for secondary medical personnel working with these doctors, for paramedics of paramedic- obstetric stations (paramedic health centers) in case they are assigned the functions of the attending physician.The guidelines can be used by public health physicians, heads of primary health care facilities and their divisions.


  • Open Access

    Outpatient follow-up of hypertensive patients by a primary care physician. Guidelines

    by O. M. Drapkina, S. A. Boytsov, I. V. Atyunina, S. A. Berns, O. N. Dzhioeva, L. Yu. Drozdova, P. V. Ipatov, A. M. Kalinina, Zh. D. Kobalava, D. V. Nebieridze, et al.

    The guidelines have been developed to standardize and optimize approaches to the follow-up of hypertensive outpatients. They are based on the latest Russian clinical guidelines, standards and procedures for the healthcare provision. Key attention is paid to outpatient follow-up, risk factors, prevention of complications, as well as drug and non-drug treatment.The guidelines present algorithms for outpatient follow-up, methods for blood pressure monitoring, criteria for drug and non-drug therapy prescription, as well as approaches to medical rehabilitation. Particular attention is paid to an individualized approach, adherence to therapy, monitoring the effectiveness of treatment and interdisciplinary interaction.The guidelines are intended for district internists, general practitioners (family doctors), district internists of the shop medical district, as well as for secondary medical personnel working with these doctors, for paramedics of paramedic- obstetric stations (paramedic health centers) in case they are assigned the functions of the attending physician.The guidelines can be used by public health physicians, heads of primary health care facilities and their divisions.


  • Open Access

    Doctors and Pharmacists: Colleagues or Competitors? Expert Council Resolution

    by O. M. Drapkina, E. V. Nevolina, L. Yu. Drozdova, A. V. Kontsevaya, T. A. Kunyaeva, M. A. Livzan, E. A. Lavrenova, A. A. Svishcheva, R. N. Shepel, A. A. Yafarova

    Division of the professional competencies of doctors and pharmacists is especially relevant due to increasing seeking medical advice by population from a pharmacy rather than a medical organization. This trend is driven by a shortage of physicians, difficulties in scheduling appointments, and long waiting times for consultations. Pharmacists are forced to go beyond their competencies, posing risks both to patients and to the professionals themselves, who are not authorized to diagnose diseases or prescribe treatments. The easy accessibility of overthe-counter medications, the vast amount of online health information, and aggressive pharmaceutical advertising contribute to the misconception that a physician’s consultation is not essential before taking medications. Selfmedication increases the risk of adverse reactions and severe consequences. Therefore, doctors and pharmacists must collaborate to address this issue.Lack of communication between specialists is another challenge. Physicians prescribe treatments without always considering the availability, cost, and alternatives of medications in pharmacies. In turn, pharmacists may suggest substitutions without a complete understanding of the patient’s clinical condition. In addition, their legal status in consulting is limited, since they can only inform about pharmacy products, which limits their role in disease prevention. On December 19, 2024, as part of the International Congress "Therapy and Preventive Medicine", the All-Russian Conference "Doctors and Pharmacists: Colleagues or Competitors?" was held. Experts discussed pressing issues and proposed solutions. The key theses of the Expert Council’s resolution are presented in this article.


  • Regional features of hospital admissions and outpatient medical care among adults with chronic obstructive pulmonary disease

    by Shepel, A.A. Svishcheva, V.P. Lusnikov, A.V. Kontsevaya, O.M. Drapkina

    OBJECTIVE To analyze the indicators of hospitalizations and outpatient visits of adults with chronic obstructive pulmonary disease (COPD) in federal districts (FD) and regions of the Russian Federation from the perspective of the World Health Organization concept of ambulatory care sensitive conditions. MATERIAL AND METHODS We analyzed data from annual forms of federal statistics (forms No. 12 and No. 14). These reports contain data on the number of hospitalizations and outpatient visits of adults diagnosed with COPD (ICD-10: J44) in 2022. RESULTS In FD with indicator of outpatient visits for adults higher that mean Russian value (Siberian, Volga, Ural), indicator of hospitalization of adults was higher than mean Russian parameter. Conversely, indicators of hospitalizations were lower in FD with lower indicators of outpatient visits of adults (Far Eastern, Southern, North-Western, Central). The exception was the North Caucasus Federal District, where the indicator of outpatient visits was lower than mean Russian value, but indicators of hospitalizations were higher. We analyzed the ratio of hospitalizations to outpatient visits for primary health care. The highest value for adults was found in the North Caucasus Federal District, and heterogeneity of this indicator within this FD was the highest compared to other FDs. The lowest ratio of hospitalizations to outpatient visits for primary health care was observed in the Ural Federal District, while heterogeneity of indicator within the district was the lowest compared to other FDs. The lowest ratio for people >65 years old was noted in the Ural Federal District, while the lowest ratio for people aged 18-64 years was in the Volga Federal District and the Siberian Federal District. There was high variability in this ratio in all constituent entities of the Russian Federation and FDs. This indicator varied from 4.4 in the Voronezh region to 127.7 in the Republic of North Ossetia-Alania. CONCLUSION Using the ACSC analysis approach, we assessed the number of hospitalizations and outpatient visits to primary care facilities among adults (18 years and older) with COPD, as well as their ratio by regions of the Russian Federation. A high variability of both the number of hospitalizations and outpatient visits to primary health care facilities and the ratio coefficient among all constituent entities of the Russian Federation and FDs was established. Accounting for diseases that can be treated at the outpatient stage may become one of the tools for assessing the quality of medical care provided to the adult population in primary health care facilities. However, before including this indicator as a criterion for assessing the quality of medical services, a deeper understanding of the reasons influencing its change is required.